Cargando…

Parasite Prolyl Oligopeptidases and the Challenge of Designing Chemotherapeuticals for Chagas Disease, Leishmaniasis and African Trypanosomiasis

The trypanosomatids Trypanosoma cruzi, Leishmania spp. and Trypanosoma brucei spp. cause Chagas disease, leishmaniasis and human African trypanosomiasis, respectively. It is estimated that over 10 million people worldwide suffer from these neglected diseases, posing enormous social and economic prob...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bastos, I.M.D, Motta, F.N, Grellier, P, Santana, J.M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778648/ https://www.ncbi.nlm.nih.gov/pubmed/23514419 http://dx.doi.org/10.2174/0929867311320250006

Ejemplares similares

Prolyl Oligopeptidase From Leishmania infantum: Biochemical Characterization and Involvement in Macrophage Infection
por: Lasse, Camila, et al.
Publicado: (2020)

Mycobacterium tuberculosis Prolyl Oligopeptidase Induces In vitro Secretion of Proinflammatory Cytokines by Peritoneal Macrophages
por: Portugal, Brina, et al.
Publicado: (2017)

The role of prolyl oligopeptidase, understanding the puzzle
por: García-Horsman, J. Arturo
Publicado: (2020)

Editorial: Discovery and Development of Drugs for Neglected Diseases: Chagas Disease, Human African Trypanosomiasis, and Leishmaniasis
por: Rivera, Gildardo, et al.
Publicado: (2021)

Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
por: Tenorio-Laranga, Jofre, et al.
Publicado: (2010)

Prolyl Oligopeptidase, Inositol Phosphate Signalling and Lithium Sensitivity
por: Harwood, Adrian J
Publicado: (2011)

Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine
por: Bivona, Augusto E., et al.
Publicado: (2018)

Kinetic Landscape of a Peptide Bond-Forming Prolyl Oligopeptidase
por: Czekster, Clarissa M., et al.
Publicado: (2017)

Intrinsic basis of thermostability of prolyl oligopeptidase from Pyrococcus furiosus
por: Banerjee, Sahini, et al.
Publicado: (2021)

Crystal Structures of Trypanosoma brucei Oligopeptidase B Broaden the Paradigm of Catalytic Regulation in Prolyl Oligopeptidase Family Enzymes
por: Canning, Peter, et al.
Publicado: (2013)

The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including Atherosclerosis
por: Waumans, Yannick, et al.
Publicado: (2015)

Distribution, classification, domain architectures and evolution of prolyl oligopeptidases in prokaryotic lineages
por: Kaushik, Swati, et al.
Publicado: (2014)

Removal of prolyl oligopeptidase reduces alpha-synuclein toxicity in cells and in vivo
por: Svarcbahs, Reinis, et al.
Publicado: (2018)

The MSDIN family in amanitin-producing mushrooms and evolution of the prolyl oligopeptidase genes
por: Luo, Hong, et al.
Publicado: (2018)

Inhibition of Prolyl Oligopeptidase Prevents Consequences of Reperfusion following Intestinal Ischemia
por: Filippone, Alessia, et al.
Publicado: (2021)

Exploration of the One-Bead One-Compound Methodology for the Design of Prolyl Oligopeptidase Substrates
por: Comellas, Gemma, et al.
Publicado: (2009)

Analysis of salt-bridges in prolyl oligopeptidase from Pyrococcus furiosus and Homo sapiens
por: Bandyopadhyay, Amal Kumar, et al.
Publicado: (2019)

Cholinesterase and Prolyl Oligopeptidase Inhibitory Activities of Alkaloids from Argemone platyceras (Papaveraceae)
por: Siatka, Tomáš, et al.
Publicado: (2017)

Cyclotides Isolated From Violet Plants of Cameroon Are Inhibitors of Human Prolyl Oligopeptidase
por: Gattringer, Jasmin, et al.
Publicado: (2021)

Prolyl oligopeptidase inhibition ameliorates experimental pulmonary fibrosis both in vivo and in vitro
por: Cucinotta, Laura, et al.
Publicado: (2023)

Compounds from African Medicinal Plants with Activities Against Selected Parasitic Diseases: Schistosomiasis, Trypanosomiasis and Leishmaniasis
por: Simoben, Conrad V., et al.
Publicado: (2018)

Recent Developments in Drug Discovery for Leishmaniasis and Human African Trypanosomiasis
por: Nagle, Advait S., et al.
Publicado: (2014)

Management of trypanosomiasis and leishmaniasis
por: Barrett, Michael P., et al.
Publicado: (2012)

Prolyl Oligopeptidase Inhibition Attenuates Steatosis in the L02 Human Liver Cell Line
por: Zhou, Da, et al.
Publicado: (2016)

Therapeutic Effect of Novel Cyanopyrrolidine-Based Prolyl Oligopeptidase Inhibitors in Rat Models of Amnesia
por: Zolotov, Nikolay N., et al.
Publicado: (2021)

2-Imidazole as a Substitute for the Electrophilic Group Gives Highly Potent Prolyl Oligopeptidase Inhibitors
por: Pätsi, Henri T., et al.
Publicado: (2021)

Methotrexate and Cyclosporine Treatments Modify the Activities of Dipeptidyl Peptidase IV and Prolyl Oligopeptidase in Murine Macrophages
por: Olivo, R. A., et al.
Publicado: (2008)

Inhibition of Human Prolyl Oligopeptidase Activity by the Cyclotide Psysol 2 Isolated from Psychotria solitudinum
por: Hellinger, Roland, et al.
Publicado: (2015)

Diversity of MSDIN family members in amanitin-producing mushrooms and the phylogeny of the MSDIN and prolyl oligopeptidase genes
por: He, Zhengmi, et al.
Publicado: (2020)

Directed-Mutagenesis of Flavobacterium meningosepticum Prolyl-Oligopeptidase and a Glutamine-Specific Endopeptidase From Barley
por: Osorio, Claudia E., et al.
Publicado: (2020)

Prolyl Oligopeptidase Regulates Dopamine Transporter Oligomerization and Phosphorylation in a PKC- and ERK-Independent Manner
por: Julku, Ulrika H., et al.
Publicado: (2021)

The Protective Role of Prolyl Oligopeptidase (POP) Inhibition in Kidney Injury Induced by Renal Ischemia–Reperfusion
por: Casili, Giovanna, et al.
Publicado: (2021)

Computer-Aided Drug Discovery Identifies Alkaloid Inhibitors of Parkinson's Disease Associated Protein, Prolyl Oligopeptidase
por: Kulkarni, Apoorva M., et al.
Publicado: (2021)

Sexual transmission of American trypanosomiasis in humans: a new potential pandemic route for Chagas parasites
por: Araujo, Perla F, et al.
Publicado: (2017)

EXPERIMENTAL TRYPANOSOMIASIS: ITS APPLICATION IN CHEMOTHERAPEUTIC INVESTIGATIONS
por: Pearce, Louise, et al.
Publicado: (1918)

Historical aspects of American trypanosomiasis (Chagas' disease)
por: Cueto, Marcos
Publicado: (1998)

Structural Analysis of Prolyl Oligopeptidases Using Molecular Docking and Dynamics: Insights into Conformational Changes and Ligand Binding
por: Kaushik, Swati, et al.
Publicado: (2011)

Prolyl Oligopeptidase from the Blood Fluke Schistosoma mansoni: From Functional Analysis to Anti-schistosomal Inhibitors
por: Fajtová, Pavla, et al.
Publicado: (2015)

Suppression of Tumor Growth in Mice by Rationally Designed Pseudopeptide Inhibitors of Fibroblast Activation Protein and Prolyl Oligopeptidase()
por: Jackson, Kenneth W., et al.
Publicado: (2015)

The Inhibition of Prolyl Oligopeptidase as New Target to Counteract Chronic Venous Insufficiency: Findings in a Mouse Model
por: Casili, Giovanna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h123lal5gfv2kmssk77mokijcv